1887

Journal of General Virology header logo

Volume 75, Issue 2

Lauric acid inhibits the maturation of vesicular stomatitis virus Free

Abstract

In the presence of lauric acid (C12), the production of infectious vesicular stomatitis virus (VSV) was inhibited in a dose-dependent manner. The inhibitory effect was reversible: after removal of C12 the antiviral effect disappeared. In addition, the chain length of the monocarboxylic acids proved to be crucial, as those with shorter or longer chains were less effective or had no antiviral activity. Concomitant with the C12-induced inhibition was the stimulation of triacylglycerol synthesis, increasing the amount up to ninefold. Analysis of the antiviral mechanism of C12 revealed that the correct assembly of the viral components was disturbed, but viral RNA and protein synthesis remained unimpaired. By cell fractionation and Western blot analysis the amount of viral M protein located in the plasma membrane was found to be markedly reduced after treatment with Cl2, whereas in the cytoplasm the quantity of M protein was similar to that in untreated cells. C12 did not influence M protein synthesis, but prevented the binding of M protein to the host cell membrane, where the protein plays an essential role in virus assembly. Thus, treatment of VSV-infected cells with C12 resulted in inhibition of virus release. It is suggested that the newly synthesized triacylglycerols might interact with the host cell plasma membrane and interfere with virus maturation.

  • Received:
  • Accepted:
  • Published Online:
© Society for General Microbiology 1994
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-2-353
1994-02-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/2/JV0750020353.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-2-353&mimeType=html&fmt=ahah

References

  1. Aloia R. C., Jensen F. C., Curtain C. C., Mobley P. W., Gordon L. M. 1988; Lipid composition and fluidity of the immunodeficiency virus. Proceedings of the National Academy of Sciences, U.S.A 85900–904
     [Google Scholar]
  2. Banerjee A. K. 1987a; The transcription complex of vesicular stomatitis virus. Cell 48:363–364
     [Google Scholar]
  3. Banerjee A. K. 1987b; Transcription and replication of rhabdo- viruses. Microbiological Reviews 51:66–87
     [Google Scholar]
  4. Bligh E. G., Dyer W. J. 1959; A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 37:911–917
     [Google Scholar]
  5. Brugh M. 1977; Butylated hydroxytoluene protects chickens exposed to Newcastle disease virus. Science 197:1291–1292
     [Google Scholar]
  6. Cave D. R., Hagen F. S., Palma E. L., Huang A. S. 1984; Detection of vesicular stomatitis virus RNA and its defective interfering particles in individual mouse brains. Journal of Virology 41:821–832
     [Google Scholar]
  7. Deckelbaum R. J., Shipley G. G., Small D. M. 1977; Structure and interactions of lipids in human plasma low density lipoproteins. Journal of Biological Chemistry 252:744–754
     [Google Scholar]
  8. Denning G. M., Figard P. H., Kaduce T. L., Spector A. A. 1983; Role of triglycerides in endothelial cell arachidonic acid metabolism. Journal of Lipid Research 24:993–1001
     [Google Scholar]
  9. Dingley A. J., King N. J. C., King G. F. 1992; An NMR investigation of the changes in plasma membrane triglyceride and phospholipid precursors during the activation of T-lymphocytes. Biochemistry 31:9098–9106
     [Google Scholar]
  10. Dubovi E. J., Wagner R. R. 1977; Spatial relationship of the proteins of vesicular stomatitis virus: induction of reversible oligomers by cleavable protein cross-linkers and oxidation. Journal of Virology 22:500–509
     [Google Scholar]
  11. Freitas I., Pontiggia P., Barni S., Bertone V., Parente M., Novarina A., Roveta G., Gerzeli G., Stoward P. 1990; Histochemical probes for the detection of hypoxic tumour cells. Anticancer Research 10:613–622
     [Google Scholar]
  12. Gavino V. C., Miller J. S., Dillman J. M., Milo G. E., Cornwell D. G. 1981; Polyunsaturated fatty acid accumulation in the lipids of cultured fibroblasts and smooth muscle cells. Journal of Lipid Research 22:57–62
     [Google Scholar]
  13. Holmes K. T., Dyne M., Williams P. G., May G. L., Tripp E., Wright L. C., Mountford C. E. 1989; Vinblastine sensitivity of leukaemic lymphoblasts modulated by serum lipid. FEBS Letters 244:103–107
     [Google Scholar]
  14. Hornung B., Amtmann E., Sauer G. 1992; Medium chain length fatty acids stimulate triacylglycerol synthesis in tissue culture cells. Biochemical Pharmacology 43:175–181
     [Google Scholar]
  15. Kim K. S., Moom H. M., Sapienza V., Carp R. I., Pullarkat R. 1978; Inactivation of cytomegalovirus and Semliki Forest virus by butylated hydroxytoluene. Journal of Infectious Diseases 138:91–94
     [Google Scholar]
  16. Knipe D. M., Baltimore D., Lodish H. F. 1977; Separate pathways of maturation of the major structural proteins of vesicular stomatitis virus. Journal of Virology 21:1128–1139
     [Google Scholar]
  17. Krieg P., Amtmann E., Sauer G. 1983; The simultaneous extraction of high-molecular-weight DNA and of RNA from solid tumors. Analytical Biochemistry 134:288–294
     [Google Scholar]
  18. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
     [Google Scholar]
  19. Lefrancois L., Lyles D. S. 1982; The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. Virology 121:157–167
     [Google Scholar]
  20. Lyte M., Shinitzky M. 1985; A special mixture for membrane fluidization. Biochimica et biopltysica acta 821:133–138
     [Google Scholar]
  21. Mackenzie C. G., Mackenzie J. B., Reiss O. K., Philpott D. E. 1966; Regulation of cell lipid metabolism and accumulation. IV. The isolation and composition of cytoplasmic lipid-rich particles. Biochemistry 5:1454–1461
     [Google Scholar]
  22. Mackinnon W. B., May G. L., Mountford C. E. 1992; Esterified cholesterol and triglyceride are present in plasma membranes of Chinese hamster ovary cells. European Journal of Biochemistry 205:827–839
     [Google Scholar]
  23. Mancarella D. A., Lenard J. 1981; Interaction of wild type and mutant M protein of vesicular stomatitis virus with viral nucleocapsid and envelope in intact virions. Evidence from (125I) iodon-aphthyl azide labeling and specific cross-linking. Biochemistry 20:6872–6877
     [Google Scholar]
  24. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
     [Google Scholar]
  25. May G. L., Wright L. C., Holmes K. T., Williams P. G., Smith I. C. P., Wright P. E., Fox R. M., Mountford C. E. 1986; Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride. Journal of Biological Chemistry 261:3048–3053
     [Google Scholar]
  26. Mellert W., Amtmann E., Erfle V., Sauer G. 1988; Inhibition of HIV-1 replication by an antiviral xanthate compound in vitro. AIDS Research and Human Retroviruses 4:71–81
     [Google Scholar]
  27. Mountford C. E., Wright L. C. 1988; Organization of lipids in the plasma membranes of malignant and stimulated cells: a new model. Trends in Biochemical Sciences 13:172–177
     [Google Scholar]
  28. Mountford C. E., Grossman G., Reid G., Fox R. M. 1982; Characterization of transformed cells and tumors by proton nuclear magnetic resonance spectroscopy. Cancer Research 42:2270–2276
     [Google Scholar]
  29. Mountford C. E., Wright C. L., Holmes K. T., Mackinnon W. B., Gregory P., Fox R. M. 1984; High-resolution proton nuclear magnetic resonance analysis of metastatic cancer cells. Science 226:1415–1418
     [Google Scholar]
  30. Music L., Sauer G. 1992; Inhibition of Moloney murine leukaemia virus transcription by a phospholipase-C inhibitor affecting trans-acting factors. Antiviral Chemistry and Chemotherapy 3:283–291
     [Google Scholar]
  31. Ono K., Dubois-Dalcq M. E., Schubert M., Lazzarini R. A. 1987; A mutated membrane protein of vesicular stomatitis virus has an abnormal distribution within the infected cell and causes defective budding. Journal of Virology 61:1332–1341
     [Google Scholar]
  32. Pepinsky R. B., Vogt V. M. 1979; Identification of retrovirus matrix proteins by lipid-protein cross-linking. Journal of Molecular Biology 131:819–837
     [Google Scholar]
  33. Rigby P. W. J., Dieckmann M., Rhodes C., Berg P. 1977; Labelling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. Journal of Molecular Biology 113:237–251
     [Google Scholar]
  34. Sarin P. S., Gallo R. C., Scheer D. I., Crews F., Lippa A.S. 1985; Effect of a novel compound (AL 721) on the HTLV-III infectivity in vitro. New England Journal of Medicine 14:1289–1290
     [Google Scholar]
  35. Sauer G., Amtmann E., Melber K., Knapp A., Muller K., Hummel K., Scherm A. 1984; DNA and RNA virus species are inhibited by xanthates, a class of antiviral compounds with unique properties. Proceedings of the National Academy of Sciences, U.S.A 813263–3267
     [Google Scholar]
  36. Schaffner C. P., Plescia O. J., Pontani D., Sun D., Thornton A., Pandey R. C., Sarin P. S. 1986; Antiviral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell culture. Biochemical Pharmacology 35:4110–4113
     [Google Scholar]
  37. Schneeberger E. E., Lynch R. D., Geyer R. P. 1971; Formation and disappearance of triglyceride droplets in strain L fibroblasts. Experimental Cell Research 69:193–206
     [Google Scholar]
  38. Snipes W., Person S., Keith A., Cupp J. 1975; Butylated hydroxytoluene inactivates lipid-containing viruses. Science 188:64–66
     [Google Scholar]
  39. Spector A. A., Mathur S. N., Kaduce T. L., Hyman B. T. 1981; Lipid nutrition and metabolism of cultured mammalian cells. Progress in Lipid Research 19:155–186
     [Google Scholar]
  40. Stevens N. M., Engle C. G., Fisher P. B., Mechlinski W., Schaffner C. P. 1975; In vitro antiherpetic activity of water- soluble amphotericin B methyl ester. Archives of Virology 48:391–394
     [Google Scholar]
  41. Suissa M. 1982; Spectrophotometric quantitation of silver grain eluted from autoradiograms. Analytical Biochemistry 133:511–514
     [Google Scholar]
  42. Sze D. Y., Jardetzky O. 1990; Characterization of lipid composition in stimulated human lymphocytes by 1H-NMR. Biochimica et biophysica acta 1054:198–206
     [Google Scholar]
  43. Tall A. R., Small D. M., Atkinson D., Rudel L. R. 1978; Studies on the structure of low density lipoproteins isolated from Macaca fascicularis fed an atherogenic diet. Journal of Clinical Investigation 62:1354–1363
     [Google Scholar]
  44. Zakowski J. J., Wagner R. R. 1980; Localisation of membrane- associated proteins in vesicular stomatitis virus by use of hydrophobic membrane probes and cross-linking reagents. Journal of Virology 36:93–102
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-2-353
Loading
Lauric acid inhibits the maturation of vesicular stomatitis virus
J. Gen. Virol. 75, 353 (1994); https://doi.org/10.1099/0022-1317-75-2-353
/content/journal/jgv/10.1099/0022-1317-75-2-353
/content/journal/jgv/10.1099/0022-1317-75-2-353
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error